Don't want ads? Subscribe or login now.

Pharma Co. Says Ex-CEO's Bias Allegations Come Up Short

By Caroline Simson · January 9, 2025, 7:48 PM EST

Canadian biopharmaceutical company FSD Pharma Inc. is urging the Third Circuit to affirm the enforcement of a $2 million arbitral award against its ex-CEO, arguing Wednesday that the former executive's allegations...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

FSD Pharma Inc v. Raza Bokhari

Case Number

24-2282

Court

Appellate - 3rd Circuit

Nature of Suit

3896 Arbitration

Date Filed

July 18, 2024

Recent Articles By Caroline

November 27, 2024
Ex-Disney Cruise Line Employee's Claim Sent To London
November 04, 2024
Justices Nix Ex-Adviser's Manifest Disregard Challenge
October 31, 2024
Ex-Citadel Reps Can't Escape Trade Secrets Suit
October 10, 2024
Ousted Chair's Claims To Go Before Arbitrator, Judge Says
October 03, 2024
Masseuse's Claim Must Be Arbitrated, Cruise Line Says
October 03, 2024
Ex-Hedge Fund Star Won't Get Additional $14.4M
May 20, 2024
Justices Turn Away Hospital Construction Feud
May 16, 2024
High Court Decision Requiring A Stay Raises More Questions
May 16, 2024
Justices Say Courts Must Stay Suits Sent To Arbitration
May 01, 2024
5th Circ. Nixes Use Of US Law In Maritime Malaria Dispute